NCI Navigant Consulting Inc.

Navigant Cymetrix Recognized with 2017 KLAS Category Leader Award for Excellence in Revenue Cycle Outsourcing

Navigant Cymetrix has been recognized as the top revenue cycle outsourcing provider in the “2017 Best in KLAS Awards: Software & Services” report.

As a comprehensive revenue cycle management solutions provider, Navigant Cymetrix offers services that range from patient registration through full account resolution. Solutions include patient access services, health information management and patient financial services, and a revenue integrity program.

“We are honored to be recognized as the leader in this category,” said David Zito, managing director and Navigant healthcare segment leader. “Navigant has expanded its revenue cycle capabilities to meet the growing needs of our clients. Our end-to-end revenue cycle outsourcing solutions use a customized approach that integrates revenue cycle expertise and best-practice processes with innovative proprietary technology.

“It is our goal to help healthcare providers achieve improved operational efficiencies in this complex environment while providing excellent customer service to the communities they serve,” Zito said. “Our collaborative solutions are designed to help transform our clients’ overall revenue cycle performance and support long-term sustainability.”

“The Best in KLAS report celebrates and recognizes vendors who have made significant strides to improve healthcare while addressing changes like payment reform and the shift to population health,” said Adam Gale, president of KLAS. “The KLAS team applauds your efforts and acknowledges your commitment to innovation and achievement. As the years go by, we are continually humbled by the number of providers who share their experiences with us; they make all our reports, especially our Best in KLAS report, possible.”

To determine the annual Best in KLAS ranking, KLAS utilizes both performance data and customer satisfaction ratings gathered in interviews from thousands of healthcare executives across the country. In 2012, 2013 and 2015/2016, Navigant Cymetrix was recognized with a Best in KLAS Award, ranking first in the Extended Business Office Services category for each of those years.

About Navigant Cymetrix

Navigant Cymetrix, a wholly owned subsidiary of Navigant Consulting, Inc., provides healthcare organizations and physician practices with comprehensive revenue cycle management solutions. Its solutions have the flexibility to accommodate the specific needs of each client and are designed to achieve high revenue cycle performance with a seamless process integrating Patient Access Services, Revenue Integrity Services, Health Information Management and Patient Financial Services. More information about Navigant Cymetrix can be found at navigantcymetrix.com.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant’s professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the Firm primarily serves clients in the healthcare, energy and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, Navigant’s practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at navigant.com.

EN
01/02/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Navigant Consulting Inc.

NAVIGANT CNSL.INCO. is slightly downgraded to Slightly Positive due to...

The independent financial analyst theScreener just slightly lowered the general evaluation of NAVIGANT CNSL.INCO. (US), active in the Business Support Services industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As o...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2019 04 17

BZH currently trades near recent lows relative to UAFRS-based (Uniform) Earnings, with a 6.7x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to decline from 11% in 2018 to 5% in 2023, accompanied by 1% Uniform Asset growth going forward. However, analysts have bullish expectations, projecting Uniform ROA to expand to 13% through 2020, accompanied by 3% Uniform Asset shrinkage. Moreover, management is confident in structural plan options, their balanced growth...

Valens Research
  • Valens Research

NCI - Embedded Expectations Analysis - 2019 04 11

Navigant Consulting Inc. (NCI:USA) currently trades below recent averages relative to UAFRS-based (Uniform) Earnings, with a 15.6x Uniform P/E. Even at these levels, the market is pricing in expectations for Uniform ROA to improve from a low of 9% in 2018 to 11% in 2023. Specifically, markets appear optimistic about the competitive position of the firm's remaining industry segments and the potential to drive top-line growth. However, they may be skeptical of the benefits of a simplified portfol...

MarketLine Department
  • MarketLine Department

ICF International, Inc. - Mergers & Acquisitions (M&A), Partnerships &...

Summary Marketline's ICF International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by ICF International, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of th...

2 directors sold after exercising options/sold

Two Directors at Navigant Consulting Inc sold after exercising options/sold 49,598 shares at between 24.120USD and 24.240USD. The significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch